← SynDRA
SETANAXIB
SynDRA canonical compound SYN0039837 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | NOX1 | NOX4 |
|---|
| Mechanism of action | NADPH oxidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- NOX1 INHIBITOR
- NADPH oxidase 1 inhibitor
- NOX4 INHIBITOR
- NADPH oxidase 4 inhibitor
- CYBB INHIBITOR
- NOX5 INHIBITOR
- NOX4 MODULATOR
Cross-references
Synonyms
- GKT-137831
- GKT-831
- GKT-01
- NADPH oxidase inhibitor (oral, renal cancer/ idiopathic pulmonary fibrosis), GenKyoTex
- GKT 137831
- GKT 831
- GKT831
- setanaxibum
- RefChem:182612
- DTXCID7075923
- GKT137831
- MFCD27923122
- UNII-45II35329V
- Setanaxib [WHO-DD]
- SETANAXIB [INN]
- GKT137831(Setanaxib)?
- Setanaxib (GKT137831)
- GTPL9932
- orb1301074
- SCHEMBL1302603
- SCHEMBL29362127
- SCHEMBL29375704
- EX-A577
- GLXC-06001
- BDBM50628591
- EBC-44352
- s7171
- AKOS022176138
- CCG-268595
- CS-3290
- SB19230
- NCGC00378460-03
- NCGC00378460-05
- NCGC00378460-08
- NCGC00378460-09
- AC-33132
- AS-74753
- DA-33605
- FG137680
Look up SETANAXIB in the interactive SynDRA portal →